268 related articles for article (PubMed ID: 22370250)
1. New pharmacological approaches to atrial fibrillation.
Milnes JT; Madge DJ; Ford JW
Drug Discov Today; 2012 Jul; 17(13-14):654-9. PubMed ID: 22370250
[TBL] [Abstract][Full Text] [Related]
2. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
[TBL] [Abstract][Full Text] [Related]
3. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
Runge S; Dietz R; Haverkamp W
Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
[TBL] [Abstract][Full Text] [Related]
4. Vernakalant hydrochloride for the treatment of atrial fibrillation.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
[TBL] [Abstract][Full Text] [Related]
5. Drug therapy for atrial fibrillation.
Musco S; Conway EL; Kowey PR
Med Clin North Am; 2008 Jan; 92(1):121-41, xi. PubMed ID: 18061001
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic therapy in atrial fibrillation.
Ravens U
Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation: pharmacological therapy.
Patel C; Salahuddin M; Jones A; Patel A; Yan GX; Kowey PR
Curr Probl Cardiol; 2011 Mar; 36(3):87-120. PubMed ID: 21392636
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
Savelieva I; John Camm A
Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic approaches to rhythm versus rate control in atrial fibrillation--where are we now?
Wyse DG
Int J Cardiol; 2006 Jun; 110(3):301-12. PubMed ID: 16516313
[TBL] [Abstract][Full Text] [Related]
10. Dronedarone: an overview.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
[TBL] [Abstract][Full Text] [Related]
11. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
[TBL] [Abstract][Full Text] [Related]
12. New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?
Morrow JP; Cannon CP; Reiffel JA
Am Heart J; 2007 Nov; 154(5):824-9. PubMed ID: 17967585
[TBL] [Abstract][Full Text] [Related]
13. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
Savelieva I; Camm J
Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
[TBL] [Abstract][Full Text] [Related]
14. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
Pamukcu B; Lip GY
Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
Roy D; Rowe BH; Stiell IG; Coutu B; Ip JH; Phaneuf D; Lee J; Vidaillet H; Dickinson G; Grant S; Ezrin AM; Beatch GN;
J Am Coll Cardiol; 2004 Dec; 44(12):2355-61. PubMed ID: 15607398
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
Camm J
Int J Cardiol; 2012 Mar; 155(3):362-71. PubMed ID: 21708411
[TBL] [Abstract][Full Text] [Related]
17. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
Crijns HJ
Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
[TBL] [Abstract][Full Text] [Related]
18. Dronedarone: an emerging therapy for atrial fibrillation.
Rosei EA; Salvetti M
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
[TBL] [Abstract][Full Text] [Related]
19. New pharmacological targets and treatments for atrial fibrillation.
Carlsson L; Duker G; Jacobson I
Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
[TBL] [Abstract][Full Text] [Related]
20. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
Wegener FT; Ehrlich JR; Hohnloser SH
J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
